Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Baxter
Colorcon
Johnson and Johnson
McKinsey

Last Updated: January 30, 2023

Triamcinolone acetonide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for triamcinolone acetonide and what is the scope of patent protection?

Triamcinolone acetonide is the generic ingredient in twenty-seven branded drugs marketed by Abbvie, Chattem Sanofi, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Cosette, Encube, Fougera Pharms, Glenmark Pharms Ltd, Lupin, Macleods Pharms Ltd, Micro Labs, Morton Grove, Mylan, Padagis Us, Pharmaderm, Pharmafair, Strides Pharma, Taro, Taro Pharm Inds Ltd, Topiderm, Crown Labs, Savage Labs, Pacira Pharms Inc, Apothecon, Amneal, Eugia Pharma, Long Grove Pharms, Mylan Labs Ltd, Parnell, Sandoz Inc, Teva Pharms Usa, Watson Labs, Allergan, Novartis, Akorn, Pai Holdings Pharm, Quagen, Wockhardt Bio Ag, Cintex Svcs, Glenmark Pharms, Novel Labs Inc, Padagis Israel, Cmp Pharma Inc, Lyne, Lupin Atlantis, Sanofi Aventis Us, Perrigo Pharma Intl, Sun Pharm Inds Inc, Rising, and Bausch And Lomb Inc, and is included in one hundred and thirty-five NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has one hundred and fifty-two patent family members in twenty-nine countries.

There are twenty-six drug master file entries for triamcinolone acetonide. Sixty-five suppliers are listed for this compound.

Drug Prices for triamcinolone acetonide

See drug prices for triamcinolone acetonide

Drug Sales Revenue Trends for triamcinolone acetonide

See drug sales revenues for triamcinolone acetonide

Recent Clinical Trials for triamcinolone acetonide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kartal City HospitalN/A
University of Southern CaliforniaEarly Phase 1
Oxular LimitedPhase 2

See all triamcinolone acetonide clinical trials

Pharmacology for triamcinolone acetonide
Medical Subject Heading (MeSH) Categories for triamcinolone acetonide

US Patents and Regulatory Information for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm Inds Ltd TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 040037-001 Sep 30, 1994 AT RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sun Pharm Inds Inc KENALOG triamcinolone acetonide SPRAY;TOPICAL 012104-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Astellas ARISTOCORT triamcinolone acetonide OINTMENT;TOPICAL 080750-004 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Teva TRIACET triamcinolone acetonide CREAM;TOPICAL 084908-002 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis TRIESENCE triamcinolone acetonide INJECTABLE;INTRAVITREAL 022048-001 Nov 29, 2007 See Plans and Pricing See Plans and Pricing
Abbvie AZMACORT triamcinolone acetonide AEROSOL, METERED;INHALATION 018117-001 Apr 23, 1982 See Plans and Pricing See Plans and Pricing
Chattem Sanofi NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 See Plans and Pricing See Plans and Pricing
Chattem Sanofi NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for triamcinolone acetonide

Country Patent Number Title Estimated Expiration
South Korea 20160005735 안구용 주사를 위한 장치 및 방법 (APPARATUS AND METHODS FOR OCULAR INJECTION) See Plans and Pricing
Chile 2013000347 Poblacion de microparticulas que comprenden un corticoesteroide clase b incorporado en una matriz formada por un copolimero de acido lactico y acido glicolico, donde dicho corticoesteroide comprende entre 22% a 28% de las microparticulas; preparacion de liberacion controlada; formulacion; y metodo de fabricacion. See Plans and Pricing
Japan 5581227 See Plans and Pricing
Israel 222638 התקנים למתן תרופה לרקמה עינית על ידי מיקורמחט ותכשירים עבורם (Devices for drug delivery to ocular tissue comprising a microneedle and compositions for use therein) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Dow
Moodys
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.